Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Hemophilia A”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Not applicableStudy completedNCT02634723
What this trial is testing

Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 21
Large-scale testing (Phase 3)Study completedNCT01507896
What this trial is testing

BAX 326 Surgery Study in Hemophilia B Patients

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Testing effectiveness (Phase 2)Looking for participantsNCT06379789
What this trial is testing

Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Who this might be right for
Hemophilia B
Regeneron Pharmaceuticals 130
Not applicableStudy completedNCT04165135
What this trial is testing

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

Who this might be right for
Severe Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A
Hoffmann-La Roche 103
Testing effectiveness (Phase 2)Study completedNCT00994929
What this trial is testing

Efficacy and Safety of IL-11 in DDAVP Unresponsive

Who this might be right for
Hemophilia AVon Willebrand Disease
University of Pittsburgh 9
Post-approval studies (Phase 4)Study completedNCT03449342
What this trial is testing

Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT00162019
What this trial is testing

Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients

Who this might be right for
Hemophilia A
Baxalta now part of Shire 56
Not applicableStudy completedNCT01034904
What this trial is testing

Health Related Quality of Life of Youth and Young Adults With Hemophilia A

Who this might be right for
Hemophilia A
CSL Behring 48
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Large-scale testing (Phase 3)Study completedNCT01335061
What this trial is testing

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07226206
What this trial is testing

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

Who this might be right for
Hemophilia A
Hoffmann-La Roche 5
Large-scale testing (Phase 3)Study completedNCT03569891
What this trial is testing

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Who this might be right for
Hemophilia B
CSL Behring 67
Not applicableUnknownNCT01505946
What this trial is testing

Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors

Who this might be right for
Severe Hemophilia A With Inhibitor
Grifols Italia S.p.A 25
Large-scale testing (Phase 3)Study completedNCT01286779
What this trial is testing

BAX 326 (rFIX) Continuation Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 117
Large-scale testing (Phase 3)Looking for participantsNCT05145127
What this trial is testing

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Pfizer 245
Not applicableStudy completedNCT05568524
What this trial is testing

Resistance Training With Blood Flow Restriction in Hemophilia

Who this might be right for
Hemophilia
University of Valencia 20
Not applicableStudy completedNCT00195221
What this trial is testing

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Who this might be right for
Hemophilia BAllergic Reactions
Wyeth is now a wholly owned subsidiary of Pfizer 166
Not applicableUnknownNCT02280265
What this trial is testing

Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A

Who this might be right for
Hemophilia A
Nanjing Medical University 15
Large-scale testing (Phase 3)Study completedNCT01488994
What this trial is testing

BAX 326 Pediatric Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 23
Load More Results